KYLE VAUGHN: Open Payments
NPI 1841739141 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 87 payments from 20 companies in 2025. Trend: 2023 $1,360 · 2024 $1,904 · 2025 $2,216
Food & beverage: $2,211Education: $5
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 12 | $356 |
| Ardelyx, Inc. | 12 | $222 |
| Otsuka America Pharmaceutical, Inc. | 8 | $216 |
| Amgen Inc. | 8 | $200 |
| Novartis Pharmaceuticals Corporation | 7 | $185 |
| Mallinckrodt Hospital Products Inc. | 5 | $153 |
| GlaxoSmithKline, LLC. | 7 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $139 |
| Calliditas Therapeutics US Inc. | 3 | $126 |
| AKEBIA THERAPEUTICS INC | 3 | $85 |
Products named: IBSRELA, JYNARQUE, ACTHAR, Fabhalta, JARDIANCE, TARPEYO, TAVNEOS, Vafseo.
Industry payments across VA — which companies pay providers there.
